Osaic Holdings
RUBY

Osaic Holdings’s Rubius Therapeutics, Inc RUBY Stock Holding History

Osaic Holdings’s Portfolio RUBY Stock Details RUBY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-325
Closed -$57 – 7655
2022
Q4 		$57 Buy
+325
New +$89 ﹤0.01% 7126
2020
Q3 		– Sell
-468
Closed -$3K – 6506
2020
Q2 		$3K Buy
+468
New +$2.76K ﹤0.01% 5724

Other funds holding RUBY

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return

Osaic Holdings's RUBY Position: Q1 2023 in Review

Osaic Holdings sold out of Rubius Therapeutics, Inc (RUBY) in Q1 2023, closing a stake of 325 shares — an estimated $57 sold.

Osaic Holdings first reported a position in RUBY in Q2 2020 and held it in 2 quarters. The position peaked at $3K in Q2 2020. 7 funds tracked by Wall St. Rank hold RUBY as of Q1 2023.

  • Osaic Holdings reported no remaining Rubius Therapeutics, Inc position as of Q1 2023 after selling out during the quarter.
  • Osaic Holdings sold 325 Rubius Therapeutics, Inc shares in Q1 2023, an estimated $57.
  • Osaic Holdings first reported a position in Rubius Therapeutics, Inc in Q2 2020 and held it in 2 quarters.
  • Osaic Holdings's Rubius Therapeutics, Inc position peaked at $3K in Q2 2020.
  • 7 funds tracked by Wall St. Rank held Rubius Therapeutics, Inc as of Q1 2023.

Based on Osaic Holdings's 13F filing for Q1 2023, filed 12 May 2023.